Sat, February 22, 2025
[ Sat, Feb 22nd 2025 ]: TechCrunch
Augury and Hightouch are in the unicorn club
[ Sat, Feb 22nd 2025 ]: Forbes
From Memes To $500 Million In Revenue: The Pump.Fun Phenomenon
[ Sat, Feb 22nd 2025 ]: eNCA
Organisations want Finance Minister to speak on SME's on 2025 budget
[ Sat, Feb 22nd 2025 ]: AOL
Mercedes-Benz won't be following Tesla and Elon Musk into robotaxis
[ Sat, Feb 22nd 2025 ]: GOBankingRates
I'm a Bank Teller: 9 Reasons You Should Never Ask for $2 Bills From the Bank
[ Sat, Feb 22nd 2025 ]: AOL
America's foremost DEI shareholder activist warns .. sity groups are forcing companies to underperform
[ Sat, Feb 22nd 2025 ]: Week99er
Qubetics Secures $13.5M as the Best Crypto Presal .. ile Litecoin Price Prediction Shake Up the Market
[ Sat, Feb 22nd 2025 ]: Kiplinger
Social Security Fairness Act Adds to Pressure on Safety Net
[ Sat, Feb 22nd 2025 ]: MSN
Leadership and business culture in startups: How to build a motivated team
[ Sat, Feb 22nd 2025 ]: MSN
'Carol from accounts': Row erupts at Cheshire West and Chester Council meeting
[ Sat, Feb 22nd 2025 ]: Tuko
University of Kabianga Advertises 20 Vacancies for Job Seekers
[ Sat, Feb 22nd 2025 ]: CNN
Dow tumbles more than 700 points as inflation and tariff fears mount
[ Sat, Feb 22nd 2025 ]: MSN
After 150 Years of Friendship, the U.S. and Canada Come to Blows
[ Sat, Feb 22nd 2025 ]: MSN
Local business sues city over issues related to rail development
[ Sat, Feb 22nd 2025 ]: Kiplinger
Five Wins for Federal Employees in the Social Security Fairness Act
Fri, February 21, 2025
[ Fri, Feb 21st 2025 ]: Inc
What Would Trump Taking Control of the USPS Mean for You?
[ Fri, Feb 21st 2025 ]: jacobin
US Economic Decline Has Been Greatly Exaggerated
[ Fri, Feb 21st 2025 ]: Marketplace
What do you want to know about business or the economy?
[ Fri, Feb 21st 2025 ]: Calendar
Ditch the Juggling Act: 12 Ways Automated Scheduling Will Revolutionize Your Life (and Business)
[ Fri, Feb 21st 2025 ]: Politico
Three potential pitfalls for phase 2 Gaza talks
[ Fri, Feb 21st 2025 ]: Salon
Why you should consider freezing your credit right now
[ Fri, Feb 21st 2025 ]: coloradopolitics
Colorado House committee votes to advance bill to adjust state's pay structure for tipped workers
[ Fri, Feb 21st 2025 ]: CNN
Target is getting hit from all sides on DEI
[ Fri, Feb 21st 2025 ]: manilatimes
BIR, Customs collections higher in January - Recto
[ Fri, Feb 21st 2025 ]: Fortune
What if AI creates more jobs than it destroys?
[ Fri, Feb 21st 2025 ]: Investopedia
MercadoLibre Stock Sets All-Time High as Q4 Earnings Blow Past Estimates
[ Fri, Feb 21st 2025 ]: Reuters
Tariffs, federal government spending cuts restrain US business activity
[ Fri, Feb 21st 2025 ]: AOL
What type of business savings account is right for you?
[ Fri, Feb 21st 2025 ]: Kiplinger
UnitedHealth Stock Drags on the Dow After DOJ Probe News
[ Fri, Feb 21st 2025 ]: Kiplinger
Block Stock Falls After Revenue, Earnings Miss Expectations
[ Fri, Feb 21st 2025 ]: Reuters
Exclusive: Abrdn to launch China asset management venture with Citic unit, sources say
[ Fri, Feb 21st 2025 ]: Forbes
Section 382 Limitations For Tech Companies Dealing With R&D Capitalization Requirements
[ Fri, Feb 21st 2025 ]: Reuters
Block shares drop as spending slowdown puts BNPL expansion in focus
[ Fri, Feb 21st 2025 ]: Forbes
Progress Over Perfection: Empowering Finance Teams With Digital Fluency
[ Fri, Feb 21st 2025 ]: Forbes
She Earns More: Redefining Power And Partnership In Modern Families
[ Fri, Feb 21st 2025 ]: AOL
Should you sign a loan or pay a fee to get your tax refund early? Here's what you need to know
[ Fri, Feb 21st 2025 ]: Bloomberg
Trump's Tariff Wars Leave US Small Business With Nowhere to Hide
[ Fri, Feb 21st 2025 ]: MSN
Europe's Economic Stagnation Persists, Latest Business Surveys Say
[ Fri, Feb 21st 2025 ]: Fortune
Starbucks hoped mobile orders and the drive-throu .. ss. New CEO Brian Niccol says that was a mistake.
[ Fri, Feb 21st 2025 ]: MSN
Two Rivers Heroes Arcade owner says he'll close if business doesn't improve
[ Fri, Feb 21st 2025 ]: Zawya
Microsoft AI Tour showcases groundbreaking AI inn .. ons driving transformation and growth across Oman
[ Fri, Feb 21st 2025 ]: MSN
India's F&B on Ventilator: Archit Singhal's Eye-Opening Book Calls for Urgent Industry Reforms
[ Fri, Feb 21st 2025 ]: MSN
French business activity contracts much more than expected in February, PMI shows
[ Fri, Feb 21st 2025 ]: cnbctv18
Unsecured loans and digital risks: RBI and bank officials flag challenges
[ Fri, Feb 21st 2025 ]: Reuters
UK runs record January budget surplus but misses forecasts
[ Fri, Feb 21st 2025 ]: Bloomberg
Bessent Plans First Call With China Counterpart on Friday
[ Fri, Feb 21st 2025 ]: Forbes
The Future Of Wall Street And Enterprise: Fintech 50 2025
[ Fri, Feb 21st 2025 ]: Outlookindia
For Banking Technologist Girish Wali, The Real-Wo .. n Of AI Is A Necessity For The Present And Future

AstraZeneca Secures China Rights to Anemia Drug, Buying FibroGen Unit in $160M Deal

By selling its China business to AstraZeneca, FibroGen can focus on developing a prostate cancer drug and potentially resuming development of roxadustat in another indication.
AstraZeneca has acquired the rights to develop and commercialize an anemia drug in China by purchasing a unit of FibroGen for $160 million. This deal includes the drug roxadustat, which is already approved in China for treating anemia caused by chronic kidney disease (CKD) and chemotherapy-induced anemia in patients with various cancers. Roxadustat, an oral medication, works by mimicking the body's response to low oxygen levels, thereby stimulating the production of red blood cells. This acquisition not only strengthens AstraZeneca's presence in the Chinese market but also expands its portfolio in treatments for anemia, a condition often associated with significant morbidity in CKD patients. The transaction is part of AstraZeneca's strategy to enhance its offerings in innovative treatments and to leverage the growing healthcare market in China.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/money/general/astrazeneca-secures-china-rights-to-anemia-drug-buying-fibrogen-unit-in-160m-deal/ar-AA1zxf6q ]